Home8CC • FRA
add
Cocrystal Pharma Inc
Previous close
€0.85
Day range
€0.85 - €1.30
Year range
€0.71 - €2.80
Market cap
20.82M USD
Avg Volume
167.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.92M | 395.98% |
Net income | -2.43M | 25.72% |
Net profit margin | — | — |
Earnings per share | -0.17 | 46.88% |
EBITDA | -2.47M | 22.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.02M | -28.75% |
Total assets | 9.71M | -27.82% |
Total liabilities | 3.38M | -14.04% |
Total equity | 6.33M | — |
Shares outstanding | 13.79M | — |
Price to book | 1.84 | — |
Return on assets | -61.54% | — |
Return on capital | -72.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.43M | 25.72% |
Cash from operations | -1.74M | 45.06% |
Cash from investing | 0.00 | — |
Cash from financing | 1.03M | — |
Net change in cash | -704.00K | 77.72% |
Free cash flow | -1.13M | 41.30% |
About
Founded
2006
Headquarters
Website
Employees
11
